Global

Argos Therapeutics, Inc. (NASDAQ:ARGS) Technical Analysis Indicators

Argos Therapeutics, Inc. (NASDAQ:ARGS) fell by -0.12% in Thursday’s trading session from $0.17 to $0.17 and has now fallen 4 consecutive sessions. The price has fallen in 6 of the last 10 days and is down by -5.07% over the same course of time. There was a decrease in both volume and price. This is usually interpreted as a good sign as traders widely believe falling stock should see declining volume. Traded activity experienced a fall of -3.63 million shares and in total 6.06 M shares exchanged hands for about $1.03 million.

Inside ARGS’s Recent Trend

Argos Therapeutics, Inc. (ARGS) lies in the middle of a very wide and falling trend in the short term and pointed towards extra losses. Short-term traders are anticipated to see a retreat of -41.98% over the course of a quarter and, with 90% chance the price will be floating in the range of $0.06 and $0.11 in this timeframe.

Argos Therapeutics, Inc. Technical Signals



ARGS has witnessed its long term and short term MA triggering a sell signal. Many traders watch for long-term averages to cross above short-term averages to signal the beginning of a downtrend. Upon corrections, the price will meet resistance from the averages between $0.18 and $0.19. A buy signal will be generated if it crosses above any of these levels. Its pivot point high generated sell signal on Monday October 09, 2017, which calls for additional declines until the stock forms a new pivot point low, as this could be a buying opportunity. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Argos Therapeutics, Inc. (NASDAQ:ARGS) Support And Resistance Levels

Argos Therapeutics, Inc. (ARGS) recorded volume accumulation so there will probably be a surplus of buyers at $0.17. In case of gains, the next resistance from accumulated volume will not be far away from today’s level at $0.17, $0.18 and $0.20.




Accumulated volume is going to prevent the price from rising further at $0.17 and this action will lead the price to take a temporary pause or stay muted for a few days.

Argos Therapeutics, Inc. (ARGS) Risk Assessment

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be high risk. In the most recent session, the stock price hovered around $0.02 between high and low, or 8.88%. For the last week the stock has had a daily average volatility of 15.98%.

Previous ArticleNext Article

Related Post

CareDx, Inc (NASDAQ:CDNA) Gives Positive Technical... CareDx, Inc (NASDAQ:CDNA) gained 13.79% in Wednesday’s session, going up from its prior closing price of $1.16 to $1.32. The price has fallen in 5 of ...
MBIA Inc. (NYSE:MBI) Sentiment Based on the Techni... MBIA Inc. (NYSE:MBI) fell by -0.57% in Tuesday’s trading session from $8.73 to $8.68. The price has fallen in 7 of the last 10 days and is down by -11...
Sequans Communications S.A. (SQNS): Does This Move... Sequans Communications S.A. (NYSE:SQNS) seems to be forming a pattern of major movements, providing only some crumbs of outlook for market participant...
Kinross Gold Corporation (KGC) Daily Technical Rev... Kinross Gold Corporation (NYSE:KGC) fell by -4.20% in Wednesday’s trading session from $4.52 to $4.33 and has now fallen 4 consecutive sessions. The p...
How Does the Fundamental Picture Look for CytRx Co... CytRx Corporation (NASDAQ:CYTR) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of 95.03M...